Archivio

Nelfinavir doses should be increased in infants less than 3 months

Current evidence for the use of pediatric antiretroviral therapy – a PENTA analysis

Variable use of therpaeutic interventions for children with human immunodeficiency virus type 1 infection in Europe.

Reconstitution of the T-cell Pool in Treated, HIV-infected Children

Immune repopulation after HAART in previously untreated HIV-1 infected children

A randomised trial evaluating three NRTI regimens with and without Nelfinavir in HIV-infected children: 48 week follow-up from the PENTA 5 trial

Drug resistance in a trial of nucleoside analogue and protease inhibitor therapy in children (PENTA 5)